[{"Assets_0_Q3_USD":336828445.0,"CommonStockSharesOutstanding_0_Q3_shares":95207637.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":159225017.0,"NetIncomeLoss_1_Q3_USD":20335708.0,"NetIncomeLoss_3_Q3_USD":56269944.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":94935471.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":93364102.0,"StockholdersEquity_0_Q3_USD":226225228.0,"EarningsPerShareBasic_1_Q3_USD":0.21,"EarningsPerShareBasic_3_Q3_USD":0.6,"Ticker":"ARWR","CIK":"879407","name":"ARROWHEAD PHARMACEUTICALS, INC.","OfficialName":"Arrowhead Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4797362481.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190805"}]